Treatment-resistant ulcerative colitis (UC) responds well to intensive fecal transplantation, producing clinical improvement in more than half of patients who receive the therapy, researchers in Australia have found.
One in four patients resistant to or intolerant of conventional nonbiologic treatment met the primary composite clinical and endoscopic end point, the researchers reported. The multicenter, randomized, placebo-controlled study included 81 patients with active UC, making it the